Latest Consumer Staples News

Maggie Beer Holdings will retain Hampers and Gifts Australia after deciding third-party proposals failed to reflect the business's value. The decision shifts the focus from a potential sale to a turnaround strategy for a business that generated $41.4 million in FY26 sales but only a 2.5% EBITDA margin.

Australian Vintage has returned to positive operating cash flow, but its FY26 statutory loss widened sharply after a $27 million inventory write-down and deferred tax charge. The wine group is betting that Poco Vino growth, further restructuring and lower stock levels can convert the cash improvement into debt reduction in FY27.

Treasury Wine Estates has reiterated its FY27 earnings guidance after a bruising year marked by a $1.1 billion statutory loss, a suspended dividend and a major US reset. Early trading indicators are improving, but the recovery now depends on execution across costs, inventory, supply and the Americas review.

Bubs Australia delivered 9.2% revenue growth and a sharp underlying EBITDA improvement in FY26, but statutory losses, weaker margins and negative operating cash flow expose the cost of its expansion. Permanent US FDA authorisation removes a major regulatory hurdle, while the annual report still flags material uncertainty around ongoing funding and cash generation.

Elixinol Wellness has lifted combined hemp sales 12% to $6.41 million in the first nine months of 2026, while unaudited gross profit rose 41%. Two major grocery programs are now fully supplied through 2027, with Hemp Gold Protein due back at Costco in Australia and New Zealand.

Yowie Group’s FY26 loss narrowed sharply after cost reductions and a non-cash loan impairment reversal, but revenue fell 27% and operating cash flow turned deeply negative. The confectionery maker remains loss-making, has negative net assets and faces uncertainty over funding, supply and the return of its ASX quotation.

Noumi has secured court approval to put Arrovest’s proposed takeover and option cancellation schemes to shareholders and optionholders. The next significant disclosure is the scheme booklet, including the independent expert’s report.

OMG Group has reported its first positive quarterly EBITDA, with preliminary Q1 FY27 net sales rising 59% to approximately $1.92 million. The result marks a potential inflection point for the health and wellness food company, although the figures remain unaudited and do not establish cash profitability.

Nutritional Growth Solutions has completed its acquisition of Sprout Organic, installing founder Selasi Berdie as CEO and reshaping the group around infant, toddler and children’s nutrition. The deal lifts shares on issue to 964 million, while management targets A$870,000 in annualised savings.

Delegat Group delivered record operating earnings and cash flow in FY26, but reported profit fell after a NZ$8.7 million impairment and other fair-value adjustments. The NZX-listed wine company is forecasting higher case sales and operating NPAT of NZ$62 million to NZ$66 million for FY27.

Bubs Australia has secured permanent US FDA authorisation for three infant formula products, removing a regulatory barrier in the company’s largest market. The approval supports possible portfolio expansion and contract manufacturing, but the presentation contains no new earnings guidance or quantified financial benefit.

Metcash delivered $558 million of operating cash flow and 2.8% ex-tobacco sales growth in the first 18 weeks of FY27, but warned that cost inflation, adverse sales mix and tobacco changes will weigh on first-half earnings. The group also expects to spend a further $18 million to $20 million on its Horizon technology program.